Documentation, Drug Pricing and White Paper

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Documentation

Drug Pricing

White Paper

Exforge antitrust settlement caps Novartis’ year of legal disputes

Pharmaceutical Technology

JANUARY 6, 2023

The alleged actions violated the Hatch-Waxman Act, formally known as the “Drug Price Competition and Patent Term Restoration Act of 1984,” which allows generic manufacturers to market their generic versions of previously approved generic medications. Gilenya is an oral medication for multiple sclerosis.

Documentation

Documentation Hospitals Dosage Drug Pricing

NHC Comments on IRA Guidance Response

Putting Patients First Blog

APRIL 14, 2023

The NHC also requests that CMS highlight when and how the agency removed QALY-based metrics from consideration in MFP justification documentation. Created by and for patient organizations over 100 years ago, the NHC brings diverse organizations together to forge consensus and drive patient-centered health policy.

Drug Pricing

Drug Pricing Drug Development Documentation Communication

Pharmacist Digest

Exforge antitrust settlement caps Novartis’ year of legal disputes

NHC Comments on IRA Guidance Response

Stay Connected